| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/01/2012 | CN101724025B 一种抗肿瘤的蟾蜍多肽及其制备方法和用途 An anti-tumor toad polypeptides and preparation and use |
| 02/01/2012 | CN101709083B 一种来自蝎尾的纤溶活性蛋白及其制备方法和应用 A fibrinolytic activity protein and its preparation method and application from Heliconia's |
| 02/01/2012 | CN101602792B 一种新型抗菌脂肽及其制备和应用 A novel antibacterial lipopeptide its preparation and application |
| 02/01/2012 | CN101525388B 特异性双链rna结合蛋白嵌合体及其在病毒感染性疾病中的应用 Specific double-stranded rna binding protein chimera and its application in viral infectious diseases |
| 02/01/2012 | CN101337987B 一种用于抗白内障的靶蛋白 An anti-cataract target protein |
| 02/01/2012 | CN101209345B 一种动物基因工程干扰素α和γ复合制剂及其生产方法 An animal genetically engineered interferon-α and γ complex preparation and production method |
| 02/01/2012 | CN101153053B 骨生肽、其制备方法和其药物组合物与用途 Bone peptides, their preparation and pharmaceutical compositions and uses thereof |
| 02/01/2012 | CN101002943B 支链peg-gcsf和peg-gmcsf结合物及其制备方法 Branched peg-gcsf and peg-gmcsf conjugates and its preparation method |
| 01/31/2012 | US8108149 Method and device for diagnosing and treating insulin-like growth factor deficiency disorders |
| 01/31/2012 | US8106182 Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field |
| 01/31/2012 | US8106179 Small interfering RNA specific to sub-units α, α′and β of the Kinase Protein ck2, and the applications of the same |
| 01/31/2012 | US8106171 Nel-related type 1 polypeptide |
| 01/31/2012 | US8106159 Insecticidal toxin complex fusion protiens |
| 01/31/2012 | US8106156 PRO1120 polypeptides |
| 01/31/2012 | US8106154 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
| 01/31/2012 | US8106153 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/31/2012 | US8106152 Antimicrobial composition |
| 01/31/2012 | US8106098 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| 01/31/2012 | US8106037 Identification and treatment of estrogen responsive prostate tumors |
| 01/31/2012 | US8106019 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis |
| 01/31/2012 | US8106018 Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof |
| 01/31/2012 | US8106017 Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same |
| 01/31/2012 | US8106016 Compounds and compositions for prevention of overdose of oxycodone |
| 01/31/2012 | US8106015 Method for enhancing immune response with peptide |
| 01/31/2012 | US8106014 Methods and apparatus for enhanced growth of peripheral nerves and nervous tissue |
| 01/31/2012 | US8106013 ABC transporter ligand GATX1 |
| 01/31/2012 | US8106012 Methods for predicting effectiveness of apheresis therapy for heart failure |
| 01/31/2012 | US8106011 Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| 01/31/2012 | US8106010 Variants of pigment epithelium derived factor and uses thereof |
| 01/31/2012 | US8106009 by administering a midkine family protein, optionally in combination with other neurotrophic factors. |
| 01/31/2012 | US8106008 Compositions and methods for arthrodetic procedures |
| 01/31/2012 | US8106007 Having affinity to antithrombin III; improved pharmacokinetic properties when compared to the original polypeptides |
| 01/31/2012 | US8106006 Modified defensins and their use |
| 01/31/2012 | US8106005 Modulating apoptosis |
| 01/31/2012 | US8106003 Peptides and methods for the treatment of inflammatory disease |
| 01/31/2012 | US8106002 Anti-cancer agent comprising protein C inhibitor |
| 01/31/2012 | US8106001 Detecting abnormal levels of endometrial bleeding associated factor (ebaf) nucleic acid; down regulating expression; timing conception; isolated binding antibodies |
| 01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
| 01/31/2012 | US8105806 Process for preparing optically active amino acids using a whole-cell catalyst |
| 01/31/2012 | US8105799 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
| 01/31/2012 | US8105615 Mixture cancer immunotherapy and adjuvant; anticancer agents |
| 01/31/2012 | US8105614 Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 01/31/2012 | US8105608 Method of treatment using ligand-immunogen conjugates |
| 01/31/2012 | US8105605 Allergen formulation |
| 01/31/2012 | US8105604 WT1 modified peptide |
| 01/31/2012 | US8105603 Polypeptides that bind APRIL |
| 01/31/2012 | US8105599 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 01/31/2012 | US8105596 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 01/31/2012 | US8105594 Methods for amyloid removal using anti-amyloid antibodies |
| 01/31/2012 | US8105590 Methods of treating inflammation in neuronal tissue |
| 01/31/2012 | US8105589 Use of DR3 antibodies in the treatment of inflammatory disease |
| 01/31/2012 | US8105586 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 01/31/2012 | US8105585 For killing Group B streptococci; endopeptidase and muramidase domains |
| 01/31/2012 | US8105584 Method for treating pervasive development disorders |
| 01/31/2012 | US8105583 Solubilized CoQ-10 |
| 01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
| 01/31/2012 | US8105578 Administering interferon-sensitivity, replication-competent clonal Rna virus to mammals |
| 01/31/2012 | US8105573 Protease resistant modified IFN beta polypeptides and their use in treating diseases |
| 01/31/2012 | US8105572 Method of treating tuberculosis with interferons |
| 01/31/2012 | US8105571 Method of treating pulmonary disease with interferons |
| 01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
| 01/31/2012 | CA2528101C Cutaneous metabolic bio-activator |
| 01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
| 01/31/2012 | CA2426490C Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 01/31/2012 | CA2394938C Glyoxalase i for reducing carbonyl compounds in carbonyl stress |
| 01/31/2012 | CA2393682C Depsipeptide and congeners thereof for use as immunosuppressants |
| 01/31/2012 | CA2392221C Bovine immunodeficiency virus (biv) based vectors |
| 01/31/2012 | CA2380216C Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 01/31/2012 | CA2233670C Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/26/2012 | WO2012012718A2 Manufacture of active highly phosphorylated human n-acetylgalactosamine-6-sulfatase and uses thereof |
| 01/26/2012 | WO2012012710A2 Radiation sensitization agents for prostate cancer |
| 01/26/2012 | WO2012012656A2 Materials and methods for treating neurodegenerative diseases |
| 01/26/2012 | WO2012012461A2 Mannose receptor c type 1 (mrc1) codon optimized cell line and uses thereof |
| 01/26/2012 | WO2012012460A1 Stable glucagon formulations for the treatment of hypoglycemia |
| 01/26/2012 | WO2012012352A2 Modified peptides and proteins |
| 01/26/2012 | WO2012012300A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| 01/26/2012 | WO2012012146A2 Compositions and methods to modulate progression and onset of inflammatory bowel disease |
| 01/26/2012 | WO2012011992A2 Ricin vaccine and methods of making and using thereof |
| 01/26/2012 | WO2012011848A1 Polypeptide having antibacterial activity and suitable for producing drugs for the treatment of bacterial infections in humans |
| 01/26/2012 | WO2012011836A1 The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer |
| 01/26/2012 | WO2012011752A2 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity |
| 01/26/2012 | WO2012011621A1 Amyloid-beta clearance |
| 01/26/2012 | WO2012011486A1 Neuropathic pain reducing agent and antidepressant agent, each using neuropeptide |
| 01/26/2012 | WO2012011429A1 Sheet preparation for tissue adhesion |
| 01/26/2012 | WO2012011144A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. |
| 01/26/2012 | WO2012010675A2 Bhlh proteins and their use as drugs |
| 01/26/2012 | WO2012010626A1 An ancestral serine protease coagulation cascade exerts a novel function in early immune defense |
| 01/26/2012 | WO2012010553A1 N-terminal modified fgf21 compounds |
| 01/26/2012 | WO2012010287A1 Tubulysin analogues |
| 01/26/2012 | WO2012010266A1 Antimicrobial peptide, branched forms thereof and their use in the treatment of bacteria infections |
| 01/26/2012 | WO2012010092A1 Preparation method and use of a crystal of a peptide substance |
| 01/26/2012 | WO2011152730A3 Stable high lipid liquid formula |
| 01/26/2012 | WO2011150517A3 Xyxin fragment biomarker for diagnosis of colon cancer |
| 01/26/2012 | WO2011130347A3 Methods for enhancing axonal regeneration |
| 01/26/2012 | WO2011118928A3 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure |
| 01/26/2012 | WO2011100982A3 SUPPRESSORS OF RNA SILENCING AS MODULATORS OF miRNA LEVELS |
| 01/26/2012 | WO2011084548A3 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 01/26/2012 | WO2011081928A3 Compositions and methods for altering cocaine esterase activity |
| 01/26/2012 | US20120023616 Methods for preventing or inhibiting microbial infection of plants and plant exhibiting resistance to microbial infection |